Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.740 | 7.490 | 5.750 |
Shares | 98.720 | 98.720 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 11.441 | 12.460 |
Price to Book | 2.126 | 1.759 |
Price to Sales | 0.929 | 1.084 |
Price to Cash Flow | 6.329 | 7.167 |
Dividend Yield | 4.082 | 3.139 |
5 Years Earnings Growth | 6.936 | 10.134 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 21.310 | 15.273 |
Technology | 19.170 | 15.218 |
Consumer Defensive | 15.380 | 9.612 |
Industrials | 10.660 | 11.429 |
Financial Services | 8.530 | 17.582 |
Communication Services | 8.070 | 8.619 |
Utilities | 5.900 | 4.284 |
Consumer Cyclical | 5.370 | 10.181 |
Basic Materials | 3.500 | 5.641 |
Energy | 1.180 | 6.912 |
Real Estate | 0.940 | 1.841 |
Number of long holdings: 99
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UnitedHealth | US91324P1021 | 2.01 | 513.88 | +0.42% | |
AbbVie | US00287Y1091 | 1.92 | 161.55 | +0.17% | |
J&J | US4781601046 | 1.87 | 151.38 | +0.11% | |
Pfizer | US7170811035 | 1.73 | 28.38 | -0.21% | |
Cisco | US17275R1023 | 1.71 | 48.95 | +0.55% | |
Bristol-Myers Squibb | US1101221083 | 1.67 | 44.71 | -0.78% | |
Amgen | US0311621009 | 1.66 | 311.41 | +0.96% | |
Broadcom | US11135F1012 | 1.66 | 1,380.03 | +3.18% | |
Roche Holding Participation | CH0012032048 | 1.65 | 224.60 | -1.40% | |
Microsoft | US5949181045 | 1.62 | 416.56 | +0.69% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
US Large Cap Growth Fund Class A EU | 1.87B | 6.13 | 11.36 | 15.30 | ||
US Large Cap Growth Fund Class GA E | 1.87B | 6.15 | 11.57 | 15.54 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review